Arrowhead Pharmaceuticals, Inc. (ARWR)
70.77
+1.90
(+2.76%)
USD |
NASDAQ |
Dec 11, 16:00
70.98
+0.21
(+0.30%)
After-Hours: 18:10
Arrowhead Pharmaceuticals Free Cash Flow: 156.89M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | -401.63M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Amgen, Inc. | 11.54B |
| Novartis AG | 17.15B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 20.49M |
| Cash from Investing (Quarterly) | 72.62M |
| Cash from Financing (Quarterly) | 3.669M |
| Free Cash Flow Per Share (Quarterly) | 0.0958 |
| Free Cash Flow to Equity (Quarterly) | -7.393M |
| Free Cash Flow to Firm (Quarterly) | 22.68M |
| Free Cash Flow Yield | 1.66% |